Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Bioreactor Perfusion Systems Market Growth 2022-2028

  • LP 4928300
  • 101 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Bioreactor Perfusion Systems will have significant change from previous year. According to our (LP Information) latest study, the global Bioreactor Perfusion Systems market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Bioreactor Perfusion Systems market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Bioreactor Perfusion Systems market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bioreactor Perfusion Systems market, reaching US$ million by the year 2028. As for the Europe Bioreactor Perfusion Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Bioreactor Perfusion Systems players cover Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), and Terumo Corporation (Japan), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioreactor Perfusion Systems market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Heart-lung Machines

Perfusion Pumps

Oxygenators

Monitoring Systems

Cannulas

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

ASCs

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Getinge AB (Sweden)

Medtronic plc (Ireland)

LivaNova PLC (U.K.)

Terumo Corporation (Japan)

XENIOS AG (Germany)

Lifeline Scientific, Inc. (U.S.)

XVIVO Perfusion AB (Sweden)

Repligen Corporation (U.S.)

Spectrum Laboratories, Inc. (U.S.)

Merck KGaA (Germany)

Harvard Bioscience, Inc. (U.S.)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bioreactor Perfusion Systems Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bioreactor Perfusion Systems by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bioreactor Perfusion Systems by Country/Region, 2017, 2022 & 2028

2.2 Bioreactor Perfusion Systems Segment by Type

2.2.1 Heart-lung Machines

2.2.2 Perfusion Pumps

2.2.3 Oxygenators

2.2.4 Monitoring Systems

2.2.5 Cannulas

2.2.6 Others

2.3 Bioreactor Perfusion Systems Sales by Type

2.3.1 Global Bioreactor Perfusion Systems Sales Market Share by Type (2017-2022)

2.3.2 Global Bioreactor Perfusion Systems Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bioreactor Perfusion Systems Sale Price by Type (2017-2022)

2.4 Bioreactor Perfusion Systems Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 ASCs

2.4.4 Others

2.5 Bioreactor Perfusion Systems Sales by Application

2.5.1 Global Bioreactor Perfusion Systems Sale Market Share by Application (2017-2022)

2.5.2 Global Bioreactor Perfusion Systems Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bioreactor Perfusion Systems Sale Price by Application (2017-2022)

3 Global Bioreactor Perfusion Systems by Company

3.1 Global Bioreactor Perfusion Systems Breakdown Data by Company

3.1.1 Global Bioreactor Perfusion Systems Annual Sales by Company (2020-2022)

3.1.2 Global Bioreactor Perfusion Systems Sales Market Share by Company (2020-2022)

3.2 Global Bioreactor Perfusion Systems Annual Revenue by Company (2020-2022)

3.2.1 Global Bioreactor Perfusion Systems Revenue by Company (2020-2022)

3.2.2 Global Bioreactor Perfusion Systems Revenue Market Share by Company (2020-2022)

3.3 Global Bioreactor Perfusion Systems Sale Price by Company

3.4 Key Manufacturers Bioreactor Perfusion Systems Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bioreactor Perfusion Systems Product Location Distribution

3.4.2 Players Bioreactor Perfusion Systems Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bioreactor Perfusion Systems by Geographic Region

4.1 World Historic Bioreactor Perfusion Systems Market Size by Geographic Region (2017-2022)

4.1.1 Global Bioreactor Perfusion Systems Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bioreactor Perfusion Systems Annual Revenue by Geographic Region

4.2 World Historic Bioreactor Perfusion Systems Market Size by Country/Region (2017-2022)

4.2.1 Global Bioreactor Perfusion Systems Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bioreactor Perfusion Systems Annual Revenue by Country/Region

4.3 Americas Bioreactor Perfusion Systems Sales Growth

4.4 APAC Bioreactor Perfusion Systems Sales Growth

4.5 Europe Bioreactor Perfusion Systems Sales Growth

4.6 Middle East & Africa Bioreactor Perfusion Systems Sales Growth

5 Americas

5.1 Americas Bioreactor Perfusion Systems Sales by Country

5.1.1 Americas Bioreactor Perfusion Systems Sales by Country (2017-2022)

5.1.2 Americas Bioreactor Perfusion Systems Revenue by Country (2017-2022)

5.2 Americas Bioreactor Perfusion Systems Sales by Type

5.3 Americas Bioreactor Perfusion Systems Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bioreactor Perfusion Systems Sales by Region

6.1.1 APAC Bioreactor Perfusion Systems Sales by Region (2017-2022)

6.1.2 APAC Bioreactor Perfusion Systems Revenue by Region (2017-2022)

6.2 APAC Bioreactor Perfusion Systems Sales by Type

6.3 APAC Bioreactor Perfusion Systems Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bioreactor Perfusion Systems by Country

7.1.1 Europe Bioreactor Perfusion Systems Sales by Country (2017-2022)

7.1.2 Europe Bioreactor Perfusion Systems Revenue by Country (2017-2022)

7.2 Europe Bioreactor Perfusion Systems Sales by Type

7.3 Europe Bioreactor Perfusion Systems Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bioreactor Perfusion Systems by Country

8.1.1 Middle East & Africa Bioreactor Perfusion Systems Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bioreactor Perfusion Systems Revenue by Country (2017-2022)

8.2 Middle East & Africa Bioreactor Perfusion Systems Sales by Type

8.3 Middle East & Africa Bioreactor Perfusion Systems Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bioreactor Perfusion Systems

10.3 Manufacturing Process Analysis of Bioreactor Perfusion Systems

10.4 Industry Chain Structure of Bioreactor Perfusion Systems

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bioreactor Perfusion Systems Distributors

11.3 Bioreactor Perfusion Systems Customer

12 World Forecast Review for Bioreactor Perfusion Systems by Geographic Region

12.1 Global Bioreactor Perfusion Systems Market Size Forecast by Region

12.1.1 Global Bioreactor Perfusion Systems Forecast by Region (2023-2028)

12.1.2 Global Bioreactor Perfusion Systems Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bioreactor Perfusion Systems Forecast by Type

12.7 Global Bioreactor Perfusion Systems Forecast by Application

13 Key Players Analysis

13.1 Getinge AB (Sweden)

13.1.1 Getinge AB (Sweden) Company Information

13.1.2 Getinge AB (Sweden) Bioreactor Perfusion Systems Product Offered

13.1.3 Getinge AB (Sweden) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Getinge AB (Sweden) Main Business Overview

13.1.5 Getinge AB (Sweden) Latest Developments

13.2 Medtronic plc (Ireland)

13.2.1 Medtronic plc (Ireland) Company Information

13.2.2 Medtronic plc (Ireland) Bioreactor Perfusion Systems Product Offered

13.2.3 Medtronic plc (Ireland) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Medtronic plc (Ireland) Main Business Overview

13.2.5 Medtronic plc (Ireland) Latest Developments

13.3 LivaNova PLC (U.K.)

13.3.1 LivaNova PLC (U.K.) Company Information

13.3.2 LivaNova PLC (U.K.) Bioreactor Perfusion Systems Product Offered

13.3.3 LivaNova PLC (U.K.) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 LivaNova PLC (U.K.) Main Business Overview

13.3.5 LivaNova PLC (U.K.) Latest Developments

13.4 Terumo Corporation (Japan)

13.4.1 Terumo Corporation (Japan) Company Information

13.4.2 Terumo Corporation (Japan) Bioreactor Perfusion Systems Product Offered

13.4.3 Terumo Corporation (Japan) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Terumo Corporation (Japan) Main Business Overview

13.4.5 Terumo Corporation (Japan) Latest Developments

13.5 XENIOS AG (Germany)

13.5.1 XENIOS AG (Germany) Company Information

13.5.2 XENIOS AG (Germany) Bioreactor Perfusion Systems Product Offered

13.5.3 XENIOS AG (Germany) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 XENIOS AG (Germany) Main Business Overview

13.5.5 XENIOS AG (Germany) Latest Developments

13.6 Lifeline Scientific, Inc. (U.S.)

13.6.1 Lifeline Scientific, Inc. (U.S.) Company Information

13.6.2 Lifeline Scientific, Inc. (U.S.) Bioreactor Perfusion Systems Product Offered

13.6.3 Lifeline Scientific, Inc. (U.S.) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Lifeline Scientific, Inc. (U.S.) Main Business Overview

13.6.5 Lifeline Scientific, Inc. (U.S.) Latest Developments

13.7 XVIVO Perfusion AB (Sweden)

13.7.1 XVIVO Perfusion AB (Sweden) Company Information

13.7.2 XVIVO Perfusion AB (Sweden) Bioreactor Perfusion Systems Product Offered

13.7.3 XVIVO Perfusion AB (Sweden) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 XVIVO Perfusion AB (Sweden) Main Business Overview

13.7.5 XVIVO Perfusion AB (Sweden) Latest Developments

13.8 Repligen Corporation (U.S.)

13.8.1 Repligen Corporation (U.S.) Company Information

13.8.2 Repligen Corporation (U.S.) Bioreactor Perfusion Systems Product Offered

13.8.3 Repligen Corporation (U.S.) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Repligen Corporation (U.S.) Main Business Overview

13.8.5 Repligen Corporation (U.S.) Latest Developments

13.9 Spectrum Laboratories, Inc. (U.S.)

13.9.1 Spectrum Laboratories, Inc. (U.S.) Company Information

13.9.2 Spectrum Laboratories, Inc. (U.S.) Bioreactor Perfusion Systems Product Offered

13.9.3 Spectrum Laboratories, Inc. (U.S.) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Spectrum Laboratories, Inc. (U.S.) Main Business Overview

13.9.5 Spectrum Laboratories, Inc. (U.S.) Latest Developments

13.10 Merck KGaA (Germany)

13.10.1 Merck KGaA (Germany) Company Information

13.10.2 Merck KGaA (Germany) Bioreactor Perfusion Systems Product Offered

13.10.3 Merck KGaA (Germany) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Merck KGaA (Germany) Main Business Overview

13.10.5 Merck KGaA (Germany) Latest Developments

13.11 Harvard Bioscience, Inc. (U.S.)

13.11.1 Harvard Bioscience, Inc. (U.S.) Company Information

13.11.2 Harvard Bioscience, Inc. (U.S.) Bioreactor Perfusion Systems Product Offered

13.11.3 Harvard Bioscience, Inc. (U.S.) Bioreactor Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Harvard Bioscience, Inc. (U.S.) Main Business Overview

13.11.5 Harvard Bioscience, Inc. (U.S.) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Bioreactor Perfusion Systems Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bioreactor Perfusion Systems Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Heart-lung Machines

Table 4. Major Players of Perfusion Pumps

Table 5. Major Players of Oxygenators

Table 6. Major Players of Monitoring Systems

Table 7. Major Players of Cannulas

Table 8. Major Players of Others

Table 9. Global Bioreactor Perfusion Systems Sales by Type (2017-2022) & (K Units)

Table 10. Global Bioreactor Perfusion Systems Sales Market Share by Type (2017-2022)

Table 11. Global Bioreactor Perfusion Systems Revenue by Type (2017-2022) & ($ million)

Table 12. Global Bioreactor Perfusion Systems Revenue Market Share by Type (2017-2022)

Table 13. Global Bioreactor Perfusion Systems Sale Price by Type (2017-2022) & (USD/Unit)

Table 14. Global Bioreactor Perfusion Systems Sales by Application (2017-2022) & (K Units)

Table 15. Global Bioreactor Perfusion Systems Sales Market Share by Application (2017-2022)

Table 16. Global Bioreactor Perfusion Systems Revenue by Application (2017-2022)

Table 17. Global Bioreactor Perfusion Systems Revenue Market Share by Application (2017-2022)

Table 18. Global Bioreactor Perfusion Systems Sale Price by Application (2017-2022) & (USD/Unit)

Table 19. Global Bioreactor Perfusion Systems Sales by Company (2020-2022) & (K Units)

Table 20. Global Bioreactor Perfusion Systems Sales Market Share by Company (2020-2022)

Table 21. Global Bioreactor Perfusion Systems Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Bioreactor Perfusion Systems Revenue Market Share by Company (2020-2022)

Table 23. Global Bioreactor Perfusion Systems Sale Price by Company (2020-2022) & (USD/Unit)

Table 24. Key Manufacturers Bioreactor Perfusion Systems Producing Area Distribution and Sales Area

Table 25. Players Bioreactor Perfusion Systems Products Offered

Table 26. Bioreactor Perfusion Systems Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Bioreactor Perfusion Systems Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Bioreactor Perfusion Systems Sales Market Share Geographic Region (2017-2022)

Table 31. Global Bioreactor Perfusion Systems Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Bioreactor Perfusion Systems Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Bioreactor Perfusion Systems Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Bioreactor Perfusion Systems Sales Market Share by Country/Region (2017-2022)

Table 35. Global Bioreactor Perfusion Systems Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Bioreactor Perfusion Systems Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Bioreactor Perfusion Systems Sales by Country (2017-2022) & (K Units)

Table 38. Americas Bioreactor Perfusion Systems Sales Market Share by Country (2017-2022)

Table 39. Americas Bioreactor Perfusion Systems Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Bioreactor Perfusion Systems Revenue Market Share by Country (2017-2022)

Table 41. Americas Bioreactor Perfusion Systems Sales by Type (2017-2022) & (K Units)

Table 42. Americas Bioreactor Perfusion Systems Sales Market Share by Type (2017-2022)

Table 43. Americas Bioreactor Perfusion Systems Sales by Application (2017-2022) & (K Units)

Table 44. Americas Bioreactor Perfusion Systems Sales Market Share by Application (2017-2022)

Table 45. APAC Bioreactor Perfusion Systems Sales by Region (2017-2022) & (K Units)

Table 46. APAC Bioreactor Perfusion Systems Sales Market Share by Region (2017-2022)

Table 47. APAC Bioreactor Perfusion Systems Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Bioreactor Perfusion Systems Revenue Market Share by Region (2017-2022)

Table 49. APAC Bioreactor Perfusion Systems Sales by Type (2017-2022) & (K Units)

Table 50. APAC Bioreactor Perfusion Systems Sales Market Share by Type (2017-2022)

Table 51. APAC Bioreactor Perfusion Systems Sales by Application (2017-2022) & (K Units)

Table 52. APAC Bioreactor Perfusion Systems Sales Market Share by Application (2017-2022)

Table 53. Europe Bioreactor Perfusion Systems Sales by Country (2017-2022) & (K Units)

Table 54. Europe Bioreactor Perfusion Systems Sales Market Share by Country (2017-2022)

Table 55. Europe Bioreactor Perfusion Systems Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Bioreactor Perfusion Systems Revenue Market Share by Country (2017-2022)

Table 57. Europe Bioreactor Perfusion Systems Sales by Type (2017-2022) & (K Units)

Table 58. Europe Bioreactor Perfusion Systems Sales Market Share by Type (2017-2022)

Table 59. Europe Bioreactor Perfusion Systems Sales by Application (2017-2022) & (K Units)

Table 60. Europe Bioreactor Perfusion Systems Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Bioreactor Perfusion Systems Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Bioreactor Perfusion Systems Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Bioreactor Perfusion Systems Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Bioreactor Perfusion Systems Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Bioreactor Perfusion Systems Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Bioreactor Perfusion Systems Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Bioreactor Perfusion Systems Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Bioreactor Perfusion Systems Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Bioreactor Perfusion Systems

Table 70. Key Market Challenges & Risks of Bioreactor Perfusion Systems

Table 71. Key Industry Trends of Bioreactor Perfusion Systems

Table 72. Bioreactor Perfusion Systems Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Bioreactor Perfusion Systems Distributors List

Table 75. Bioreactor Perfusion Systems Customer List

Table 76. Global Bioreactor Perfusion Systems Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Bioreactor Perfusion Systems Sales Market Forecast by Region

Table 78. Global Bioreactor Perfusion Systems Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Bioreactor Perfusion Systems Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Bioreactor Perfusion Systems Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Bioreactor Perfusion Systems Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Bioreactor Perfusion Systems Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Bioreactor Perfusion Systems Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Bioreactor Perfusion Systems Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Bioreactor Perfusion Systems Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Bioreactor Perfusion Systems Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Bioreactor Perfusion Systems Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Bioreactor Perfusion Systems Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Bioreactor Perfusion Systems Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Bioreactor Perfusion Systems Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Bioreactor Perfusion Systems Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Bioreactor Perfusion Systems Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Bioreactor Perfusion Systems Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Bioreactor Perfusion Systems Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Bioreactor Perfusion Systems Revenue Market Share Forecast by Application (2023-2028)

Table 96. Getinge AB (Sweden) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 97. Getinge AB (Sweden) Bioreactor Perfusion Systems Product Offered

Table 98. Getinge AB (Sweden) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 99. Getinge AB (Sweden) Main Business

Table 100. Getinge AB (Sweden) Latest Developments

Table 101. Medtronic plc (Ireland) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 102. Medtronic plc (Ireland) Bioreactor Perfusion Systems Product Offered

Table 103. Medtronic plc (Ireland) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 104. Medtronic plc (Ireland) Main Business

Table 105. Medtronic plc (Ireland) Latest Developments

Table 106. LivaNova PLC (U.K.) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 107. LivaNova PLC (U.K.) Bioreactor Perfusion Systems Product Offered

Table 108. LivaNova PLC (U.K.) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 109. LivaNova PLC (U.K.) Main Business

Table 110. LivaNova PLC (U.K.) Latest Developments

Table 111. Terumo Corporation (Japan) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 112. Terumo Corporation (Japan) Bioreactor Perfusion Systems Product Offered

Table 113. Terumo Corporation (Japan) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 114. Terumo Corporation (Japan) Main Business

Table 115. Terumo Corporation (Japan) Latest Developments

Table 116. XENIOS AG (Germany) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 117. XENIOS AG (Germany) Bioreactor Perfusion Systems Product Offered

Table 118. XENIOS AG (Germany) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 119. XENIOS AG (Germany) Main Business

Table 120. XENIOS AG (Germany) Latest Developments

Table 121. Lifeline Scientific, Inc. (U.S.) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 122. Lifeline Scientific, Inc. (U.S.) Bioreactor Perfusion Systems Product Offered

Table 123. Lifeline Scientific, Inc. (U.S.) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 124. Lifeline Scientific, Inc. (U.S.) Main Business

Table 125. Lifeline Scientific, Inc. (U.S.) Latest Developments

Table 126. XVIVO Perfusion AB (Sweden) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 127. XVIVO Perfusion AB (Sweden) Bioreactor Perfusion Systems Product Offered

Table 128. XVIVO Perfusion AB (Sweden) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 129. XVIVO Perfusion AB (Sweden) Main Business

Table 130. XVIVO Perfusion AB (Sweden) Latest Developments

Table 131. Repligen Corporation (U.S.) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 132. Repligen Corporation (U.S.) Bioreactor Perfusion Systems Product Offered

Table 133. Repligen Corporation (U.S.) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 134. Repligen Corporation (U.S.) Main Business

Table 135. Repligen Corporation (U.S.) Latest Developments

Table 136. Spectrum Laboratories, Inc. (U.S.) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 137. Spectrum Laboratories, Inc. (U.S.) Bioreactor Perfusion Systems Product Offered

Table 138. Spectrum Laboratories, Inc. (U.S.) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 139. Spectrum Laboratories, Inc. (U.S.) Main Business

Table 140. Spectrum Laboratories, Inc. (U.S.) Latest Developments

Table 141. Merck KGaA (Germany) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 142. Merck KGaA (Germany) Bioreactor Perfusion Systems Product Offered

Table 143. Merck KGaA (Germany) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 144. Merck KGaA (Germany) Main Business

Table 145. Merck KGaA (Germany) Latest Developments

Table 146. Harvard Bioscience, Inc. (U.S.) Basic Information, Bioreactor Perfusion Systems Manufacturing Base, Sales Area and Its Competitors

Table 147. Harvard Bioscience, Inc. (U.S.) Bioreactor Perfusion Systems Product Offered

Table 148. Harvard Bioscience, Inc. (U.S.) Bioreactor Perfusion Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 149. Harvard Bioscience, Inc. (U.S.) Main Business

Table 150. Harvard Bioscience, Inc. (U.S.) Latest Developments

List of Figures

Figure 1. Picture of Bioreactor Perfusion Systems

Figure 2. Bioreactor Perfusion Systems Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bioreactor Perfusion Systems Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Bioreactor Perfusion Systems Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bioreactor Perfusion Systems Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Heart-lung Machines

Figure 10. Product Picture of Perfusion Pumps

Figure 11. Product Picture of Oxygenators

Figure 12. Product Picture of Monitoring Systems

Figure 13. Product Picture of Cannulas

Figure 14. Product Picture of Others

Figure 15. Global Bioreactor Perfusion Systems Sales Market Share by Type in 2021

Figure 16. Global Bioreactor Perfusion Systems Revenue Market Share by Type (2017-2022)

Figure 17. Bioreactor Perfusion Systems Consumed in Hospital

Figure 18. Global Bioreactor Perfusion Systems Market: Hospital (2017-2022) & (K Units)

Figure 19. Bioreactor Perfusion Systems Consumed in Clinic

Figure 20. Global Bioreactor Perfusion Systems Market: Clinic (2017-2022) & (K Units)

Figure 21. Bioreactor Perfusion Systems Consumed in ASCs

Figure 22. Global Bioreactor Perfusion Systems Market: ASCs (2017-2022) & (K Units)

Figure 23. Bioreactor Perfusion Systems Consumed in Others

Figure 24. Global Bioreactor Perfusion Systems Market: Others (2017-2022) & (K Units)

Figure 25. Global Bioreactor Perfusion Systems Sales Market Share by Application (2017-2022)

Figure 26. Global Bioreactor Perfusion Systems Revenue Market Share by Application in 2021

Figure 27. Bioreactor Perfusion Systems Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Bioreactor Perfusion Systems Revenue Market Share by Company in 2021

Figure 29. Global Bioreactor Perfusion Systems Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Bioreactor Perfusion Systems Revenue Market Share by Geographic Region in 2021

Figure 31. Global Bioreactor Perfusion Systems Sales Market Share by Region (2017-2022)

Figure 32. Global Bioreactor Perfusion Systems Revenue Market Share by Country/Region in 2021

Figure 33. Americas Bioreactor Perfusion Systems Sales 2017-2022 (K Units)

Figure 34. Americas Bioreactor Perfusion Systems Revenue 2017-2022 ($ Millions)

Figure 35. APAC Bioreactor Perfusion Systems Sales 2017-2022 (K Units)

Figure 36. APAC Bioreactor Perfusion Systems Revenue 2017-2022 ($ Millions)

Figure 37. Europe Bioreactor Perfusion Systems Sales 2017-2022 (K Units)

Figure 38. Europe Bioreactor Perfusion Systems Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Bioreactor Perfusion Systems Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa Bioreactor Perfusion Systems Revenue 2017-2022 ($ Millions)

Figure 41. Americas Bioreactor Perfusion Systems Sales Market Share by Country in 2021

Figure 42. Americas Bioreactor Perfusion Systems Revenue Market Share by Country in 2021

Figure 43. United States Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Bioreactor Perfusion Systems Sales Market Share by Region in 2021

Figure 48. APAC Bioreactor Perfusion Systems Revenue Market Share by Regions in 2021

Figure 49. China Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Bioreactor Perfusion Systems Sales Market Share by Country in 2021

Figure 56. Europe Bioreactor Perfusion Systems Revenue Market Share by Country in 2021

Figure 57. Germany Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Bioreactor Perfusion Systems Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Bioreactor Perfusion Systems Revenue Market Share by Country in 2021

Figure 64. Egypt Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Bioreactor Perfusion Systems Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Bioreactor Perfusion Systems in 2021

Figure 70. Manufacturing Process Analysis of Bioreactor Perfusion Systems

Figure 71. Industry Chain Structure of Bioreactor Perfusion Systems

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450